Tobacco, Alcohol, Cannabis, and Other Drug Use in the US Before and During the Early Phase of the COVID-19 Pandemic

Author:

Compton Wilson M.1,Flannagan Kerry S. J.12,Silveira Marushka L.12,Creamer MeLisa R.1,Kimmel Heather L.1,Kanel Moana12,Blanco Carlos1,Volkow Nora D.1

Affiliation:

1. National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland

2. Kelly Government Solutions, Rockville, Maryland

Abstract

ImportanceInformation about national substance use trends among youths and adults after mid-March 2020 is limited due to constraints on surveillance during the COVID-19 pandemic.ObjectiveTo evaluate whether substance use prevalence in the early part of the pandemic (2020) differed from the prepandemic periods of 2018 to 2019 and 2016 to 2018.Design, Setting, and ParticipantsThis cross-sectional study was a repeated analysis of 2016 to 2020 data from a nationally representative sample of youths and adults in the Population Assessment of Tobacco and Health (PATH) Study. Participants were representative of the US civilian noninstitutionalized population. Household residents age 13 years or older were interviewed in person from 2016 to 2019 and via telephone in 2020.ExposuresAge, calendar year.Main Outcomes and MeasuresPast 30-day self-reported use of any tobacco, any alcohol, binge drinking, cannabis, and any other illegal or misused prescription drugs.ResultsThe overall nationally representative 2020 sample included 7129 youths (ages 13-17 years), 3628 young adults (ages 18-20 years), and 8874 adults (ages ≥21 years). Comparing 2018 to 2019 with 2020 among youths, prevalence of all substances used declined (eg, cannabis use declined in those aged 16-17 years from 14.9% to 7.6%; absolute difference, −7.3 percentage points [95% CI −8.8 to −5.8 percentage points]). Among young adults, prevalence of all substances other than any alcohol decreased significantly (eg, tobacco use declined from 37.8% to 22.8%; absolute difference, −15.1 percentage points [95% CI −16.8 to −13.3 percentage points]). In adults ages 21 to 24 years, any tobacco use declined from 39.0% to 30.9% (absolute difference, −8.2 percentage points [95% CI, −10.6 to −5.7 percentage points]), and alcohol use increased from 60.2% to 65.2% (absolute difference, 5.0 percentage points [95% CI, 2.3 to 7.7 percentage points]). Among adults aged 25 years or older, any tobacco use declined from 39.0% to 30.9% (absolute difference, −8.2 percentage points [95% CI, −10.6 to −5.7 percentage points]), cannabis use increased from 11.3% to 12.4% (absolute difference, 1.2 percentage points [95% CI, 0.3 to 2.0 percentage points]), and other substance use declined from 5.8% to 3.7% (absolute difference, −2.1 percentage points [95% CI, −2.9 to −1.4 percentage points]).Conclusions and RelevanceIn this cross-sectional study, substance use decreased between 2019 and 2020 among those aged 13 to 20 years; consistent declines were not seen in older persons other than tobacco use reductions, and cannabis use increased among adults ages 25 years and older. While social changes during the COVID-19 pandemic could have affected substance use, findings should be interpreted with caution due to differences in data collection methods in 2016 to 2019 and 2020.

Publisher

American Medical Association (AMA)

Subject

General Medicine

Reference24 articles.

1. Design and methods of the Population Assessment of Tobacco and Health (PATH) Study.;Hyland;Tob Control,2017

2. Longitudinal uses of the Population Assessment of Tobacco and Health Study.;Piesse;Tob Regul Sci,2021

3. Population Assessment of Tobacco and Health (PATH) reliability and validity study: selected reliability and validity estimates.;Tourangeau;Tob Control,2019

4. Tobacco-product use by adults and youths in the United States in 2013 and 2014.;Kasza;N Engl J Med,2017

5. Pseudoreplication: further evaluation and applications of the balanced half-sample technique.;McCarthy;Vital Health Stat 2,1969

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3